⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
globenewswire.com
NVS
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study
businesswire.com
TAK
Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study
businesswire.com
BMY
FNB Harvest d'actions à revenu élevé annonce les distributions d’octobre 2026
businesswire.com
LLY
AMZN
MSFT
NVDA
COIN
PLTR
TSLA
META
AMD
AVGO
COST
GOOGL
NFLX
AAPL
HOOD
SOFI
BKNG
CRWD
JNJ
ORCL
CME
ENB
SHOP
SU
TEL
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
Archrock Announces Timing for Third Quarter 2026 Results
globenewswire.com
AROC
Rithm Capital Corp. Announces Third Quarter 2026 Results
businesswire.com
RITM
INVESTOR ALERT: Doximity, Inc. (DOCS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline - RGRD Law
globenewswire.com
DOCS
From Physical AI to Scaled Deployment: WeRide Named Among WICV 2026's Top 10 Automotive AI Application Cases
globenewswire.com
WRD
Gix Internet Shares to Trade Exclusively on Nasdaq
globenewswire.com
GIXI